Vanguard Personalized Indexing Management’s BridgeBio Pharma BBIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.41M	Buy	18,966 +1,727	+10%	+$125K	0.01%	762
2025 Q4	$1.32M	Buy	17,239 +436	+3%	+$28.6K	0.01%	788
2025 Q3	$873K	Buy	16,803 +625	+4%	+$30.5K	0.01%	973
2025 Q2	$699K	Buy	16,178 +772	+5%	+$28.1K	0.01%	1050
2025 Q1	$533K	Buy	15,406 +677	+5%	+$22.8K	0.01%	1082
2024 Q4	$404K	Buy	14,729 +2,604	+21%	+$67.3K	0.01%	1211
2024 Q3	$309K	Buy	12,125 +1,923	+19%	+$50.5K	0.01%	1332
2024 Q2	$258K	Buy	10,202 +1,617	+19%	+$44.2K	﹤0.01%	1335
2024 Q1	$265K	Buy	8,585 +1,156	+16%	+$39.3K	0.01%	1323
2023 Q4	$300K	Buy	+7,429	New	+$223K	0.01%	1223
2021 Q3	–	Sell	-4,235	Closed	-$258K	–	983
2021 Q2	$258K	Buy	+4,235	New	+$242K	0.03%	793